Revolve Wealth Partners’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-498
| Closed | -$201K | – | 241 |
|
|
2024
Q4 | $201K | Sell |
498
-289
| -37% | -$116K | 0.03% | 215 |
|
|
2024
Q3 | $366K | Sell |
787
-11
| -1% | -$5.12K | 0.06% | 135 |
|
|
2024
Q2 | $374K | Sell |
798
-2
| -0.3% | -$937 | 0.06% | 117 |
|
|
2024
Q1 | $334K | Buy |
800
+26
| +3% | +$10.9K | 0.06% | 121 |
|
|
2023
Q4 | $315K | Buy |
774
+17
| +2% | +$6.92K | 0.06% | 116 |
|
|
2023
Q3 | $263K | Sell |
757
-2
| -0.3% | -$695 | 0.06% | 121 |
|
|
2023
Q2 | $267K | Buy |
759
+39
| +5% | +$13.7K | 0.06% | 115 |
|
|
2023
Q1 | $227K | Buy |
720
+1
| +0.1% | +$315 | 0.06% | 129 |
|
|
2022
Q4 | $208K | Buy |
719
+27
| +4% | +$7.8K | 0.06% | 136 |
|
|
2022
Q3 | $200K | Sell |
692
-57
| -8% | -$16.5K | 0.07% | 125 |
|
|
2022
Q2 | $211K | Buy |
+749
| New | +$211K | 0.07% | 128 |
|